mRNA vaccines for COVID-19 are safe and effective in patients with cardiac amyloidosis

Back

HFA Premium Access

mRNA vaccines for COVID-19 are safe and effective in patients with cardiac amyloidosis

Session: ePosters in myocardial disease 2

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor G. Barzen (Berlin, DE)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Gina Barzen

Charité - University Medicine Berlin, Berlin (Germany)

0 follower

7 more presentations in this session

The risk of cardiac hospitalization and arrythmias in patients with arrhythmogenic and dilated cardiomyopathies

Speaker: Doctor M. Marques Antunes (Lisboa, PT)

Access

Abstract

Slides

Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance

Speaker: Doctor L. De Michieli (Padova, IT)

Access

Abstract

Slides

Prognostic value of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy

Speaker: Assistant Professor O. Butko (Kharkiv, UA)

Access

Abstract

Slides

Analysis of a novel myocardial functional echocardiographic parameter, left ventricular myocardial work, in patients with hyperthrophic cardiomyopathy

Speaker: Doctor G. Racz (Szeged, HU)

Access

Abstract

Slides

The kinetic of left ventricle diastolic dysfunction during pharmacotherapy up-titration in patients with dilated cardiomyopathy.

Speaker: Doctor E. Dziewiecka (Krakow, PL)

Access

Abstract

Slides

Access the full session

ePosters in myocardial disease 2

Speakers: Doctor G. Barzen, Doctor M. Marques Antunes, Doctor L. De Michieli, Assistant Professor O. Butko, Doctor G. Racz...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources